31 Jan, EOD - Indian

SENSEX 77500.57 (0.97)

Nifty 50 23508.4 (1.11)

Nifty Bank 49587.2 (0.56)

Nifty IT 42662.75 (0.56)

Nifty Midcap 100 53712.2 (1.89)

Nifty Next 50 63127.35 (1.50)

Nifty Pharma 21438.6 (0.09)

Nifty Smallcap 100 16910.5 (2.11)

31 Jan, EOD - Global

NIKKEI 225 39572.49 (0.15)

HANG SENG 20225.11 (0.14)

S&P 6141 (0.49)

LOGIN HERE

companylogoBlue Jet Healthcare Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 544009 | NSE Symbol : BLUEJET | ISIN : INE0KBH01020 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
22-Jan-2025 29-Jan-2025 Quarterly Results Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve 1.Approval of the unaudited standalone financial result for the quarter ended December 31 2024 along with Limited Review Report as received from the statutory auditors of the company Unaudited Financial results for the quarter ended 31st December, 2024 Outcome of Board meeting held today ie 29th January, 2025 (As per BSE Announcement Dated on 29/01/2025)
19-Nov-2024 19-Nov-2024 Change in Directors Pursuant to Regulation 30 read with schedule III of SEBI (LODR) Regulation 2015. we wish to inform that the Board of Directors of the Company at the meeting held today, based on the recommendation of the NRC and subject to approval of the shareholders of the Company, have unanimously approved: 1. Reappointment of the following Independent Directors for a period of 5 years: Mr. Girish P Vanvari, Ms. Divya Sameer Momaya, Ms.Preeti G Mehta. 2. Appointment of Independent Director Ms. Priyanka Yadav 3. Appointment of Mr. Popat Kedar as an Executive Director.
23-Oct-2024 29-Oct-2024 Quarterly Results Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the Unaudited Standalone Financial Results for the Quarter and Half Year ended 30th September 2024 along with Limited Review Report as received from the statutory auditors of the company. Approval of Unaudited Standalone Financial Results for the half year and quarter ended September 30, 2024 along with Limited Review Report as received from the statutory auditor of the company (As Per BSE Announcement dated on 29.10.2024)
31-Jul-2024 06-Aug-2024 Quarterly Results Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Approval of the Unaudited Standalone Financial Results for the quarter ended June 30 2024 along with Limited Review Report from the Statutory Auditor of the Company. Unaudited Financial Statement for the Quarter ended June 30, 2024 along with LRR as received from Statutory Auditors (As Per BSE Announcement dated on 06.08.2024)
17-May-2024 25-May-2024 Dividend Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to Regulation 29 and 33 of SEBI LODR Regulations 2015 we hereby inform you that the meeting of Board of directors of Bluejet Healthcare Limited is scheduled to be held on Saturday 25th May 2024 to inter alia consider the Following: 1. Approval of Audited Standalone Financial Results for the quarter and financial year ended 31st March 2024 along with audited report thereon. 2. To consider recommending final dividend on the equity shares of the Company for the financial year ended 31st March 2024 if any subject to the approval of the shareholders at the ensuring Annual General Meeting. Outcome of Board Meeting for the fourth quarter and financial year ended 31st March 2024. (As per BSE Announcement Dated on 25/05/2024)
29-Jan-2024 06-Feb-2024 Quarterly Results Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve The Financial Results for quarter ended December 31 2023 Outcome Of Board Meeting for the Third Quarter and Nine Months ended 31st December, 2023. (As per BSE Announcement Dated on 06/02/2024) Revised outcome (As Per BSE Announcement dated on 07.02.2024)
04-Nov-2023 10-Nov-2023 Quarterly Results Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of the SEBI (LODR) Regulations 2015 Approval of the Un-Audited Standalone Financial Results for the quarter and half year ended September 30, 2023 (As Per BSE Announcement Dated on 10/11/2023)

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +